What began as a targeted therapy for diabetes has rapidly evolved into a mainstream weight management solution, fueled by rising awareness, direct-to-consumer marketing, and strong clinical outcomes
The therapeutic benefits of tesofensine are attributed to this effect because each of these neurotransmitters exerts an important function at different locations in the brain
Common issues include nausea, vomiting, diarrhea, and constipation, which are typically mild to moderate and most frequent during dose escalation
SEMAGLUTIDE : Semaglutide is a GLP-1 receptor agonist that may be prescribed by a licensed medical provider as part of a medically supervised weight management program
Consumers are right to be cautious
Access and affordability remain among the greatest challenges